← Eichor
Condition: Inetetamab Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Inetetamab

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metasta
Phase 4 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06641544Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
Phase N/A · 1 location(s) · Zhejiang Cancer Hospital · NCT05856383SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd Treatment
Phase 2 · 1 location(s) · Fudan University · NCT07182721A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrot
NA · 1 location(s) · Wang Ouchen · NCT06234137
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.